Choroidal neovascularization secondary to pathological myopia-macular Bruch membrane defects as prognostic factor to anti-VEGF treatment.

João Coelho André S Ferreira Ana Carolina Abreu Sílvia MonteiroMaria João FurtadoMiguel GomesMiguel Lume

Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2021)

Macular Bruch membrane defects are often seen in mCNV and have a significant impact in visual acuity and prognosis. Eyes with macular BM defects have a poorer response and worse visual outcomes after anti-VEGF therapy.

Keyphrases

optical coherence tomography
diabetic retinopathy
prognostic factors
vascular endothelial growth factor
optic nerve
age related macular degeneration
cataract surgery
endothelial cells
combination therapy
mesenchymal stem cells
cell therapy